EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dysregulated TIE ‐2 expression is associated with blood‐brain barrier leakiness and Alzheimer's disease‐related neuropathology

Selvi Ince, Carol Van Hulle, Gwendlyn Kollmorgen, Clara Quijano-Rubio, Carey Gleason, Barbara B Bendlin, Ozioma Okonkwo, Sanjay Asthana, Kaj Blennow, Henrik Zetterberg, Sterling C Johnson, Seth Love iD und 1 weitere

Brain Pathology · 2026

DOI: 10.1111/bpa.70109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, 2026. Verfasst von Selvi Ince und 12 weiteren Autor:innen. Beteiligte Einrichtung: Cerebrovascular & Dementia Research Group, Learning and Research Building, Bristol Medical School, Translational Health Sciences, University of Brist…. Hauptthemen laut MEDLINE: Alzheimer Disease, Blood-Brain Barrier, Receptor, TIE-2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH National Center for Advancing Translational Sciences (NCATS), NCATS NIH HHS, Ministry of National Education in Türkiye.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral hypoperfusion and blood–brain barrier (BBB) leakiness are related to cognitive decline and the onset and spread of Aβ and tau pathology in Alzheimer's disease (AD). Disrupted angiopoietin/TIE (ANGPT/TIE) signalling causes neurovascular instability and BBB leakiness accelerating cognitive decline and disease pathology in mouse models of AD. To explore ANGPT/TIE signalling in human AD, we measured CSF TIE‐1 and TIE‐2 levels by ELISA in two independent clinical dementia cohorts, and serum and CSF Tie‐1/‐2 in paired CSF and serum samples from neurologically normal individuals. ANGPT1, ANGPT2, TIE‐1 and TIE‐2 levels were measured by ELISA in crude homogenate (CH) and microvessel‐enriched fractions (MVFs) of post‐mortem human parietal cortex in relation to biochemical markers of cerebral perfusion (MAG:PLP1) and BBB leakiness (parenchymal fibrinogen) in a control, AD, and vascular dementia (VaD) cohort. CSF soluble TIE‐2 was elevated in AD biomarker+ve individuals and correlated positively with CSF t‐tau and p‐tau, and markers of BBB leakiness, neuronal injury, and neuroinflammation. Tissue TIE‐2 levels were significantly reduced in Braak tangle stage (BS) III‐IV, that is, brains with early‐intermediate AD pathology, and were lower in MVFs in end‐stage AD pathology (BSV‐VI) than in controls or VaD. Lower levels of MVF TIE‐2 correlated with markers of cerebral hypoperfusion and BBB leakiness. Our study reveals a reciprocal relationship between elevated CSF and reduced tissue TIE‐2 expression that is related to markers of tau pathology, BBB leakiness, and cerebral hypoperfusion, providing novel insights into ANGPT/TIE signalling in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBlood-Brain BarrierReceptor, TIE-2HumansMaleFemaleAgedAged, 80 and overAngiopoietin-1Angiopoietin-2Biomarkerstau ProteinsBrainReceptor, TIE-1Dementia, Vascular

Stichwörter der Autor:innen

Alzheimer's diseaseBBBTIE‐1TIE‐2angiopoietin‐2blood–brain barriermild‐cognitive impairment

Substanzen

Receptor, TIE-2Angiopoietin-1Angiopoietin-2Biomarkerstau ProteinsReceptor, TIE-1TEK protein, human

Autor:innen und Institutionen

  • Cerebrovascular & Dementia Research Group, Learning and Research Building, Bristol Medical School, Translational Health Sciences, University of Bristol, Bristol, UK.
  • Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
  • Wisconsin Alzheimer's Disease Research Center, University of Wisconsin, Madison, Wisconsin, USA.
  • Roche Diagnostics GmbH, Penzberg, Germany.
  • Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
  • Wisconsin Alzheimer's Institute, University of Wisconsin, Madison, Wisconsin, USA.

ORCID-Profile: Seth Love, J Scott Miners

Förderung

  • NIH National Center for Advancing Translational Sciences (NCATS)
  • NCATS NIH HHS
  • Ministry of National Education in Türkiye
  • NIA NIH HHS
  • Alzheimer's Research UK
  • Alzheimer’s Research UK
  • National Center for Advancing Translational Sciences

Zitieren

APA

Ince, S., Van Hulle, C., Kollmorgen, G., Quijano-Rubio, C., Gleason, C., Bendlin, B. B., Okonkwo, O., Asthana, S., Blennow, K., Zetterberg, H., Johnson, S. C., Love, S., & Miners, J. S. (2026). Dysregulated TIE ‐2 expression is associated with blood‐brain barrier leakiness and Alzheimer's disease‐related neuropathology. Brain Pathology. https://doi.org/10.1111/bpa.70109

Vancouver

Ince S, Van Hulle C, Kollmorgen G, Quijano-Rubio C, Gleason C, Bendlin BB, et al. Dysregulated TIE ‐2 expression is associated with blood‐brain barrier leakiness and Alzheimer's disease‐related neuropathology. Brain Pathology. 2026. doi:10.1111/bpa.70109

BibTeX
@article{Ince2026,
  author = {Ince, Selvi and Van Hulle, Carol and Kollmorgen, Gwendlyn and Quijano-Rubio, Clara and Gleason, Carey and Bendlin, Barbara B and Okonkwo, Ozioma and Asthana, Sanjay and Blennow, Kaj and Zetterberg, Henrik and Johnson, Sterling C and Love, Seth and Miners, J Scott},
  title = {Dysregulated TIE ‐2 expression is associated with blood‐brain barrier leakiness and Alzheimer's disease‐related neuropathology},
  journal = {Brain Pathology},
  year = {2026},
  doi = {10.1111/bpa.70109}
}
Kostenlos starten →